Ani (ANIP) Reports Q1 2026 Financial Results
Ani reported total net revenue of $237.5 million for Q1 2026, a 20% year-over-year increase driven by growth in Rare Disease and Generics segments as well as out-licensing agreements. The company raised its full-year 2026 net revenue guidance to between $1.08 billion and $1.14 billion.
Tickers: $ANIP